418 related articles for article (PubMed ID: 17942555)
21. Entry of betaherpesviruses.
Nishimura M; Mori Y
Adv Virus Res; 2019; 104():283-312. PubMed ID: 31439151
[TBL] [Abstract][Full Text] [Related]
22. The HCMV gH/gL/UL128-131 complex triggers the specific cellular activation required for efficient viral internalization into target monocytes.
Nogalski MT; Chan GC; Stevenson EV; Collins-McMillen DK; Yurochko AD
PLoS Pathog; 2013; 9(7):e1003463. PubMed ID: 23853586
[TBL] [Abstract][Full Text] [Related]
23. PDGF receptor-α does not promote HCMV entry into epithelial and endothelial cells but increased quantities stimulate entry by an abnormal pathway.
Vanarsdall AL; Wisner TW; Lei H; Kazlauskas A; Johnson DC
PLoS Pathog; 2012 Sep; 8(9):e1002905. PubMed ID: 23028311
[TBL] [Abstract][Full Text] [Related]
24. Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells.
Saccoccio FM; Sauer AL; Cui X; Armstrong AE; Habib el-SE; Johnson DC; Ryckman BJ; Klingelhutz AJ; Adler SP; McVoy MA
Vaccine; 2011 Mar; 29(15):2705-11. PubMed ID: 21310190
[TBL] [Abstract][Full Text] [Related]
25. Human cytomegalovirus vaccine based on the envelope gH/gL pentamer complex.
Wussow F; Chiuppesi F; Martinez J; Campo J; Johnson E; Flechsig C; Newell M; Tran E; Ortiz J; La Rosa C; Herrmann A; Longmate J; Chakraborty R; Barry PA; Diamond DJ
PLoS Pathog; 2014 Nov; 10(11):e1004524. PubMed ID: 25412505
[TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in Human Cytomegalovirus Glycoprotein O (gO) Exert Epistatic Influences on Cell-Free and Cell-to-Cell Spread and Antibody Neutralization on gH Epitopes.
Day LZ; Stegmann C; Schultz EP; Lanchy JM; Yu Q; Ryckman BJ
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996433
[TBL] [Abstract][Full Text] [Related]
27. Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus.
Fu TM; Wang D; Freed DC; Tang A; Li F; He X; Cole S; Dubey S; Finnefrock AC; ter Meulen J; Shiver JW; Casimiro DR
Vaccine; 2012 Dec; 30(52):7469-74. PubMed ID: 23107592
[TBL] [Abstract][Full Text] [Related]
28.
Gerna G; Kabanova A; Lilleri D
Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31336680
[TBL] [Abstract][Full Text] [Related]
29. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation.
Gerna G; Percivalle E; Perez L; Lanzavecchia A; Lilleri D
J Virol; 2016 Jul; 90(14):6216-6223. PubMed ID: 27122579
[TBL] [Abstract][Full Text] [Related]
31. Mutagenesis of Human Cytomegalovirus Glycoprotein L Disproportionately Disrupts gH/gL/gO over gH/gL/pUL128-131.
Schultz EP; Yu Q; Stegmann C; Day LZ; Lanchy JM; Ryckman BJ
J Virol; 2021 Aug; 95(17):e0061221. PubMed ID: 34132577
[TBL] [Abstract][Full Text] [Related]
32. Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities.
Cui X; Cao Z; Wang S; Adler SP; McVoy MA; Snapper CM
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32294946
[TBL] [Abstract][Full Text] [Related]
33. Antibody-Independent Quantification of Cytomegalovirus Virion Protein Incorporation Using HiBiT.
Jones IKA; Streblow DN
Methods Mol Biol; 2021; 2244():213-232. PubMed ID: 33555589
[TBL] [Abstract][Full Text] [Related]
34. Influence of Human Cytomegalovirus Glycoprotein O Polymorphism on the Inhibitory Effect of Soluble Forms of Trimer- and Pentamer-Specific Entry Receptors.
Brait N; Stögerer T; Kalser J; Adler B; Kunz I; Benesch M; Kropff B; Mach M; Puchhammer-Stöckl E; Görzer I
J Virol; 2020 Jul; 94(14):. PubMed ID: 32350071
[TBL] [Abstract][Full Text] [Related]
35. Human cytomegalovirus (HCMV) glycoprotein gB promotes virus entry in trans acting as the viral fusion protein rather than as a receptor-binding protein.
Wille PT; Wisner TW; Ryckman B; Johnson DC
mBio; 2013 Jun; 4(3):e00332-13. PubMed ID: 23736286
[TBL] [Abstract][Full Text] [Related]
36. Comparative neutralizing potencies of antibodies suggest conservation as well as mechanistic differences in human cytomegalovirus entry into epithelial and endothelial cells.
Qi Y; He L; Cui X; Hertel L; Freed DC; Fu TM; Kauvar LM; McVoy MA; Ruan Q
Virol J; 2020 Apr; 17(1):50. PubMed ID: 32268919
[TBL] [Abstract][Full Text] [Related]
37. Cytomegalovirus UL131-128 products promote gB conformational transition and gB-gH interaction during entry into endothelial cells.
Patrone M; Secchi M; Bonaparte E; Milanesi G; Gallina A
J Virol; 2007 Oct; 81(20):11479-88. PubMed ID: 17686875
[TBL] [Abstract][Full Text] [Related]
38. Antigenic Characterization of the HCMV gH/gL/gO and Pentamer Cell Entry Complexes Reveals Binding Sites for Potently Neutralizing Human Antibodies.
Ciferri C; Chandramouli S; Leitner A; Donnarumma D; Cianfrocco MA; Gerrein R; Friedrich K; Aggarwal Y; Palladino G; Aebersold R; Norais N; Settembre EC; Carfi A
PLoS Pathog; 2015 Oct; 11(10):e1005230. PubMed ID: 26485028
[TBL] [Abstract][Full Text] [Related]
39. Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.
Wen Y; Monroe J; Linton C; Archer J; Beard CW; Barnett SW; Palladino G; Mason PW; Carfi A; Lilja AE
Vaccine; 2014 Jun; 32(30):3796-804. PubMed ID: 24837507
[TBL] [Abstract][Full Text] [Related]
40. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism.
Wang D; Shenk T
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18153-8. PubMed ID: 16319222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
